Results for tag: "HER2 Negative Breast Cancer Drug"

The HER2 Negative Breast Cancer Drug market is a subset of the larger Breast Cancer Drug market. HER2 Negative Breast Cancer Drugs are used to treat breast cancer that does not express the HER2 protein. These drugs are typically used in combination with other treatments such as chemotherapy, radiation, and hormone therapy. Commonly used HER2 Negative Breast Cancer Drugs include aromatase inhibitors, cyclin-dependent kinase 4/6 inhibitors, and mTOR inhibitors. These drugs are used to reduce the risk of recurrence and improve overall survival rates. Notable companies in the HER2 Negative Breast Cancer Drug market include AstraZeneca, Pfizer, Novartis, and Roche. These companies are involved in the research, development, and marketing of HER2 Negative Breast Cancer Drugs. Show Less Read more